Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Lattice was RIGHT
View:
Post by fdfd12 on May 13, 2016 6:37am

Lattice was RIGHT

Whether you like it or not, real men must admit lattice was right.
CXR has made the change that she called for.


Today was reported the following in respect to the exchange rate.

Concordia International's financial results for the first quarter ended March 31, 2016 , including revenue of $139.9 million , are based on 91 days of performance at an average foreign exchange rate of 1.4321 GBP /USD.


Previous release was

On a constant currency basis, based on an exchange rate of 1.53 USD /GBP as at October 25, 2015 .
Comment by CxrBull on May 13, 2016 7:36am
This post has been removed in accordance with Community Policy
Comment by fdfd12 on May 13, 2016 10:32am
Nobody has commented on this??? She was right wasn't she?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities